Fragile X Mental Retardation Protein: Nucleocytoplasmic Shuttling and Association with Somatodendritic Ribosomes

Fragile X syndrome, a leading cause of inherited mental retardation, is attributable to the unstable expansion of a CGG-repeat within the FMR1 gene that results in the absence of the encoded protein. The fragile X mental retardation protein (FMRP) is a ribosome-associated RNA-binding protein of uncertain function that contains nuclear localization and export signals. We show here detailed cellular localization studies using both biochemical and immunocytochemical approaches. FMRP was highly expressed in neurons but not glia throughout the rat brain, as detected by light microscopy. Although certain structures, such as hippocampus, revealed a strong signal, the regional variation in staining intensity appeared to be related to neuron size and density. In human cell lines and mouse brain, FMRP co-fractionated primarily with polysomes and rough endoplasmic reticulum. Ultrastructural studies in rat brain revealed high levels of FMRP immunoreactivity in neuronal perikarya, where it is concentrated in regions rich in ribosomes, particularly near or between rough endoplasmic reticulum cisternae. Immunogold studies also provided evidence of nucleocytoplasmic shuttling of FMRP, which was localized in neuronal nucleoplasm and within nuclear pores. Moreover, labeling was observed in large- and small-caliber dendrites, in dendritic branch points, at the origins of spine necks, and in spine heads, all known locations of neuronal polysomes. Dendritic localization, which was confirmed by co-fractionation of FMRP with synaptosomal ribosomes, suggests a possible role of FMRP in the translation of proteins involved in dendritic structure or function and relevant for the mental retardation occurring in fragile X syndrome.

[1]  S. Warren,et al.  The fragile X mental retardation protein is a ribonucleoprotein containing both nuclear localization and nuclear export signals. , 1996, Human molecular genetics.

[2]  G. Dreyfuss,et al.  Specific sequences in the fragile X syndrome protein FMR1 and the FXR proteins mediate their binding to 60S ribosomal subunits and the interactions among them , 1996, Molecular and cellular biology.

[3]  M. Olink-Coux,et al.  Localization and active transport of mRNA in axons of sympathetic neurons in culture , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[4]  É. Khandjian,et al.  The fragile X mental retardation protein is associated with ribosomes , 1996, Nature Genetics.

[5]  A. Poustka,et al.  Highly conserved 3' UTR and expression pattern of FXR1 points to a divergent gene regulation of FXR1 and FMR1. , 1995, Human molecular genetics.

[6]  É. Khandjian,et al.  Prevalence of carriers of premutation-size alleles of the FMRI gene--and implications for the population genetics of the fragile X syndrome. , 1995, American journal of human genetics.

[7]  R. Nussbaum,et al.  The fragile X mental retardation syndrome protein interacts with novel homologs FXR1 and FXR2. , 1995, The EMBO journal.

[8]  D. Nelson,et al.  Intragenic loss of function mutations demonstrate the primary role of FMR1 in fragile X syndrome , 1995, Nature Genetics.

[9]  R. Nussbaum,et al.  FXR1, an autosomal homolog of the fragile X mental retardation gene. , 1995, The EMBO journal.

[10]  J. Morris,et al.  Differential subcellular mRNA targeting: deletion of a single nucleotide prevents the transport to axons but not to dendrites of rat hypothalamic magnocellular neurons. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[11]  S. Warren,et al.  Translational suppression by trinucleotide repeat expansion at FMR1 , 1995, Science.

[12]  C. Gravholt,et al.  Quantitative comparison of FMR1 gene expression in normal and premutation alleles. , 1995 .

[13]  A. Chakravarti,et al.  Down syndrome consequent to a cryptic maternal 12p;21q chromosome translocation. , 1995, American journal of medical genetics.

[14]  M. Gassmann,et al.  Tissue-specific expression of a FMR1/β-galactosidase fusion gene in transgenic mice , 1995 .

[15]  Rosalind,et al.  Two new cases of FMR1 deletion associated with mental impairment. , 1995, American journal of human genetics.

[16]  S. Warren,et al.  Quantitative comparison of FMR1 gene expression in normal and premutation alleles. , 1995, American journal of human genetics.

[17]  S. Warren,et al.  Triplet repeat expansion mutations: the example of fragile X syndrome. , 1995, Annual review of neuroscience.

[18]  J. Eberwine,et al.  On the nature and differential distribution of mRNAs in hippocampal neurites: implications for neuronal functioning. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[19]  O. Steward,et al.  Dendrites as compartments for macromolecular synthesis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[20]  C. Burd,et al.  Conserved structures and diversity of functions of RNA-binding proteins. , 1994, Science.

[21]  Guy Nagels,et al.  Fmr1 knockout mice: A model to study fragile X mental retardation , 1994, Cell.

[22]  S. Warren,et al.  Cryptic and polar variation of the fragile X repeat could result in predisposing normal alleles , 1994, Cell.

[23]  R. Nussbaum,et al.  Essential role for KH domains in RNA binding: Impaired RNA binding by a mutation in the KH domain of FMR1 that causes fragile X syndrome , 1994, Cell.

[24]  B. Oostra,et al.  A deletion of 1.6 kb proximal to the CGG repeat of the FMR1 gene causes the clinical phenotype of the fragile X syndrome. , 1994, Human molecular genetics.

[25]  M. Morales,et al.  Aggregation of vasopressin mRNA in a subset of axonal swellings of the median eminence and posterior pituitary: light and electron microscopic evidence , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[26]  J. van Minnen RNA in the axonal domain: a new dimension in neuronal functioning? , 1994, The Histochemical journal.

[27]  W. Brown,et al.  Rapid fragile X carrier screening and prenatal diagnosis using a nonradioactive PCR test. , 1994, JAMA.

[28]  S. Warren,et al.  FMR1 protein: conserved RNP family domains and selective RNA binding. , 1993, Science.

[29]  John Calvin Reed,et al.  Investigation of the subcellular distribution of the bcl-2 oncoprotein: residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes. , 1993, Cancer research.

[30]  D. Nelson,et al.  High resolution methylation analysis of the FMR1 gene trinucleotide repeat region in fragile X syndrome. , 1993, Human molecular genetics.

[31]  J. Brosius,et al.  Transport of BC1 RNA in hypothalamo-neurohypophyseal axons , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[32]  J. Mandel,et al.  The FMR–1 protein is cytoplasmic, most abundant in neurons and appears normal in carriers of a fragile X premutation , 1993, Nature Genetics.

[33]  I. Weiler,et al.  Metabotropic glutamate receptors trigger postsynaptic protein synthesis. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[34]  R. Nussbaum,et al.  The protein product of the fragile X gene, FMR1, has characteristics of an RNA-binding protein , 1993, Cell.

[35]  B. Oostra,et al.  Characterization and localization of the FMR-1 gene product associated with fragile X syndrome , 1993, Nature.

[36]  J. Mallet,et al.  Nucleus basalis magnocellularis and hippocampus are the major sites of FMR-1 expression in the human fetal brain , 1993, Nature Genetics.

[37]  T. Bliss,et al.  Changes in protein synthesis accompanying long-term potentiation in the dentate gyrus in vivo , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[38]  David E. Housman,et al.  Tissue specific expression of FMR–1 provides evidence for a functional role in fragile X syndrome , 1993, Nature Genetics.

[39]  J. Sutcliffe,et al.  DNA methylation represses FMR-1 transcription in fragile X syndrome. , 1992, Human molecular genetics.

[40]  B. Neel,et al.  The nontransmembrane tyrosine phosphatase PTP-1B localizes to the endoplasmic reticulum via its 35 amino acid C-terminal sequence , 1992, Cell.

[41]  J. Sutcliffe,et al.  Variation of the CGG repeat at the fragile X site results in genetic instability: Resolution of the Sherman paradox , 1991, Cell.

[42]  W. Brown,et al.  Analysis of neocortex in three males with the fragile X syndrome. , 1991, American journal of medical genetics.

[43]  Ben A. Oostra,et al.  Absence of expression of the FMR-1 gene in fragile X syndrome , 1991, Cell.

[44]  J. Sutcliffe,et al.  Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome , 1991, Cell.

[45]  J. Mandel,et al.  Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome , 1991, Science.

[46]  J. Brosius,et al.  Dendritic location of neural BC1 RNA. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[47]  M. Krug,et al.  Long-term potentiation induced changes in protein synthesis of hippocampal subfields of freely moving rats: time-course. , 1991, Biomedica biochimica acta.

[48]  P. Sanna,et al.  mRNA coding for oxytocin is present in axons of the hypothalamo-neurohypophysial tract. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[49]  M. Waxham,et al.  In situ hybridization histochemistry of Ca2+/calmodulin-dependent protein kinase in developing rat brain , 1990, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[50]  I. Wool,et al.  Antiribosomal S10 antibodies in humans and MRL/lpr mice with systemic lupus erythematosus. , 1989, Arthritis and rheumatism.

[51]  N. Thompson,et al.  Inhibition of in vivo and in vitro transcription by monoclonal antibodies prepared against wheat germ RNA polymerase II that react with the heptapeptide repeat of eukaryotic RNA polymerase II. , 1989, The Journal of biological chemistry.

[52]  A. Matus,et al.  Selective localization of messenger RNA for cytoskeletal protein MAP2 in dendrites , 1988, Nature.

[53]  O. Steward,et al.  Protein-synthetic machinery beneath postsynaptic sites on CNS neurons: association between polyribosomes and other organelles at the synaptic site , 1988, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[54]  E. Castigli,et al.  Occurrence and Sequence Complexity of Polyadenylated RNA in Squid Axoplasm , 1987, Journal of neurochemistry.

[55]  T. Teyler,et al.  Long-term potentiation. , 1987, Annual review of neuroscience.

[56]  O. Steward,et al.  Protein-synthetic machinery at postsynaptic sites during synaptogenesis: a quantitative study of the association between polyribosomes and developing synapses , 1986, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[57]  S. Heffelfinger,et al.  Antibodies to bovine liver branched-chain 2-oxo acid dehydrogenase cross-react with this enzyme complex from other tissues and species. , 1983, The Biochemical journal.

[58]  P. Greengard,et al.  Synapsin I (protein I), a nerve terminal-specific phosphoprotein. III. Its association with synaptic vesicles studied in a highly purified synaptic vesicle preparation , 1983, The Journal of cell biology.

[59]  O. Steward Alterations in polyribosomes associated with dendritic spines during the reinnervation of the dentate gyrus of the adult rat , 1983, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[60]  W. Levy,et al.  Preferential localization of polyribosomes under the base of dendritic spines in granule cells of the dentate gyrus , 1982, The Journal of neuroscience : the official journal of the Society for Neuroscience.